KBR 코리아비즈니스리뷰
KBR 코리아비즈니스리뷰

SPECIAL REPORTS

Can AI Help Extend Human Life? The Current State of Medical AI

From clinical trials on AI electrocardiogram (ECG) mortality to 2026 breast cancer screening and aging marker studies, this article analyzes the proven effects and remaining limitations of medical AI. It outlines the operational conditions required for medical institutions to translate more accurate predictions into actual improvements in survival and healthy lifespan.

KBR경영연구소Published 2026년 9월 21일Updated 2026년 9월 21일
Share
Can AI Help Extend Human Life? The Current State of Medical AI

Can people live longer if they take drugs created by artificial intelligence? The study on the aging markers of ziltivekimab released in September 2026 brought this question back to the surface. However, calculated values representing biological age and actual survival duration are different.…

KBR Access

Read this KBR Analysis article now

Get full access to this article for 30 days. KBR Members can read one KBR Analysis article free every month.

KBR NEWSLETTER

Sign up for free and get the KBR Newsletter!

Sign up and opt in to the newsletter to receive KBR's curated business and economic insights by email.

Sign Up Free

LATEST IN TOPIC

Latest in this topic

RELATED CONTENT

Related Content

KBR CORE PRODUCTS